CCDC6 and thyroid gland carcinoma: Over the years, several RET/PTC rearrangements have been reported in thyroid carcinoma, all characterized by the fusion of the tyrosine kinase domain of the receptor with a ubiquitous driver gene that allows the illegitimate kinase expression in cells that commonly do not express it (i.e., follicular cells) (Figure 2A).